Designing Growth Strategies is in our DNA

Dementia Drugs Market Size, Share & Industry Analysis, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Amyloid Beta-directed Antibodies), By Indication (Alzheimer's Disease and Parkinson's Disease Dementia), By Type (Branded and Generics), By Route of Administration (Oral, Parenteral, and Others), By Treatment Type (Symptomatic Cognitive Therapies, Disease-modifying Therapies, and Behavioral & Neuropsychiatric Symptom Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated :September 8, 2026 | Format:PDF | Report ID: 118891

 

Get a Quote

man icon
Mail icon
Mail icon
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 204